Safety assessment, radioiodination and preclinical evaluation of antinuclear antibody as novel medication for prostate cancer in mouse xenograft model

This study aims to provide in vitro and in vivo data to support the utilization of antinuclear antibodies (ANAs) as novel tools for the diagnosis and treatment of prostate cancers. The hematological, biochemical, and histological toxicities of ANAs were assessed at the doses of 5 and 50 μg per mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu Minh Chau, Hoang, Lu Duc Chinh, Nguyen, Thi Khanh Giang, Nguyen, Thi Ngoc, Nguyen, Quang Chien, Nguyen, Thanh Binh, Dang, Ho Hong Quang, Bui, Van Cuong, Pham, Thanh Minh, Nguyen, Thi Thu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618443/
https://www.ncbi.nlm.nih.gov/pubmed/37907691
http://dx.doi.org/10.1038/s41598-023-45984-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618443/
https://www.ncbi.nlm.nih.gov/pubmed/37907691
http://dx.doi.org/10.1038/s41598-023-45984-6

Ejemplares similares